Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

McKinsey's 4 drug launch flavors: Good, bad, ugly and misguided
Fierce Pharma
Wed, 05/18/16 - 04:27 pm
Tags:
drug launches, JNJ, Zytiga
Consumer brands, medical devices poised for growth: J&J CEO
CNBC
Wed, 05/18/16 - 12:00 pm
Tags:
consumer health, devices, JNJ, Alex Gorsky, Pharma CEOs
J&J to stand behind talc's safety at upcoming trials -lawyer
Yahoo/Reuters
Tue, 05/17/16 - 05:15 pm
Tags:
JNJ, consumer health
Johnson & Johnson, Endo International: Feds Increase Scrutiny of Drug Industry after Valeant Saga
Bidness, ETC
Thu, 05/12/16 - 09:41 am
Tags:
JNJ, Endo International, PBMs
With competition lurking, Eli Lilly's baricitinib must show unparalled efficacy
Medical Marketing and Media
Wed, 05/11/16 - 10:52 am
Tags:
Eli Lilly, baricitinib, JAK inhibitors, Pfizer, Xeljanz, Enbrel, AbbVie, Humira, JNJ, Remicade
U.S. investigates Merck, J&J and Endo over pharmacy-benefit contracts
Marketwatch
Tue, 05/10/16 - 02:51 pm
Tags:
Merck, JNJ, Endo International, PBMs, SEC
Johnson & Johnson’s DePuy picks up BioMedical Enterprises
Mass Device
Tue, 05/10/16 - 09:44 am
Tags:
JNJ, devices, DePuy, M&A, BioMedical Enterprises, implants
J&J loses another talcum powder case, ordered to pay victim $55 million
BioPharma Dive
Thu, 05/5/16 - 09:35 am
Tags:
JNJ, ovarian cancer
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Tags:
Amgen, Kyprolis, JNJ, Bristol-Myers Squibb, Multiple Myeloma, Darzalex, Empliciti, AbbVie, Takeda, Ninlaro
J&J Faces 1,000 More Talc-Cancer Suits After Verdict Loss
Bloomberg
Mon, 05/2/16 - 10:01 pm
Tags:
JNJ
Why Johnson & Johnson Is So Optimistic These Days
Motley Fool
Thu, 04/28/16 - 02:26 pm
Tags:
JNJ
9 Things That Stand Out in Johnson & Johnson's Q1 Report
Motley Fool
Fri, 04/22/16 - 10:37 am
Tags:
JNJ, earnings
Combo of J&J Ebola vaccine, Bavarian Nordic booster yields 100% success in small-scale tests
BioPharma Dive
Thu, 04/21/16 - 03:31 pm
Tags:
JNJ, Bavarian Nordic, ebola virus, vaccines
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Tags:
Humira, Amgen, Bristol-Myers Squibb, Coherus Biosciences, Gilead Sciences, Intercept Pharma, JNJ, Novartis, Pfizer
[video]Analysts: Johnson & Johnson Likely to Do Deal in Near Term
TheStreet.com
Thu, 04/21/16 - 09:04 am
Tags:
JNJ, M&A
Why Biotech Will Benefit from Higher Drug Prices
Barron's
Wed, 04/20/16 - 06:41 pm
Tags:
biotech, drug pricing, JNJ, Gilead Sciences, Amgen, Biogen
Competition drives down sales of J&J's Olysio
Medical Marketing and Media
Tue, 04/19/16 - 06:13 pm
Tags:
JNJ, Olysio, earnings
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
Tags:
FDA, diabetes, AstraZeneca, Takeda, Nesina, Onglyza, Eli Lilly, JNJ, Trajenta, Jardiance, Invokana
Johnson & Johnson Q1 Adjusted EPS Tops Estimations, Boosts Full Year Outlook
Yahoo/Benzinga
Tue, 04/19/16 - 09:45 am
Tags:
JNJ, earnings
CFO: Why J&J's three units are best as one company
CNBC
Tue, 04/19/16 - 09:44 am
Tags:
JNJ, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.